Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

NCT03707912 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03707912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03707912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
October 9, 2018
Completion date
March 15, 2019
Enrollment
204 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory viral infections